Affaire du Sang Contaminé: State Responsibility and Public Health Scandal
The Contaminated Blood Affair (Affaire du Sang Contaminé) is one of the most serious public health scandals in modern French history. Between 1984 and 1985, the state-run blood transfusion service distributed blood products contaminated with the Human Immunodeficiency Virus (HIV) to hemophiliacs and other patients, resulting in hundreds of deaths and thousands of infections. The affair generated extensive litigation across multiple legal forums — criminal courts, the specialized Court of Justice of the Republic, administrative courts, and the European Court of Human Rights — and produced landmark decisions on ministerial criminal liability, state responsibility for public health services, and the rights of victims of medical negligence. The legal fallout from the scandal profoundly transformed French public health law, the liability regime for blood products, and the accountability of government officials.
The Facts
Throughout the early 1980s, the French blood transfusion service, under the authority of the Centre National de Transfusion Sanguine (CNTS), distributed clotting factor concentrates to treat hemophilia. Many of these products were derived from plasma collected from high-risk populations, including prisoners and paid donors, and were not subjected to heat treatment or other virus-inactivation procedures that were becoming available. By early 1985, the CNTS was aware that its products could be contaminated with HIV but continued to distribute existing stocks while awaiting the approval of heat-treated alternatives.
The delay was catastrophic. Approximately 4,000 hemophiliacs and blood transfusion recipients were infected with HIV through contaminated blood products. Over 1,200 subsequently died from AIDS-related complications. The infection also spread to sexual partners and children born to infected recipients. The scandal was compounded by evidence that CNTS and Ministry of Health officials had prioritized financial considerations over patient safety, choosing to exhaust existing stocks of untreated products rather than incur the cost of destroying them and switching immediately to heat-treated alternatives.
Criminal Proceedings Before the Ordinary Courts
The first criminal proceedings targeted the directors of the CNTS. In 1992, Dr. Michel Garretta, the CNTS director, was convicted of fraud (tromperie) and manslaughter (homicide involontaire) and sentenced to four years’ imprisonment. Dr. Jean-Pierre Allain, the CNTS scientific director, received a two-year suspended sentence. The Paris Court of Appeal upheld the convictions, and the Court of Cassation rejected the appeals. These convictions established that the distribution of untreated blood products while heat-treated alternatives were available constituted a criminal offense.
The criminal liability of lower-level officials and employees was also pursued. Several doctors and administrators were convicted for their roles in the distribution of contaminated products. The prosecutions revealed systemic failures in the governance of the blood transfusion service, including inadequate oversight by the Ministry of Health, conflicts of interest among CNTS officials, and a culture that prioritized cost containment over patient safety.
The Court of Justice of the Republic
A distinctive feature of the French legal response was the prosecution of government ministers before the Court of Justice of the Republic (Cour de Justice de la République — CJR). The CJR was established by the 1993 constitutional revision specifically in response to the contaminated blood affair and other scandals involving ministerial accountability. It has jurisdiction over crimes and délits committed by ministers in the exercise of their functions.
In 1999, the CJR charged three ministers: Laurent Fabius (Prime Minister at the time of the events), Georgina Dufoix (Minister of Social Affairs), and Edmond Hervé (Secretary of State for Health). The prosecution alleged that the ministers had failed to take timely action to ensure the safety of blood products and had been informed of the risks but did nothing. The trial before the CJR in 2004 was a historic proceeding, the first time a former Prime Minister had been tried for actions in office.
The CJR acquitted Fabius and Dufoix in 2005, finding that while there had been delays in the response, criminal intent had not been established. Hervé was convicted but granted an exemption from punishment (dispense de peine), reflecting the court’s view that while his legal responsibility was engaged, the circumstances did not warrant a penalty. The judgment was controversial, with many victims and commentators viewing the acquittals as a failure of accountability. The proceedings nonetheless established the CJR as a mechanism for ministerial accountability and set important precedents for the standard of criminal fault applicable to high-level policy decisions.
Administrative Liability
The administrative courts played a central role in securing compensation for victims. In a landmark 1995 judgment, Consorts Nguyen et autres c/ État, the Conseil d’État held the state liable for the harm caused by the distribution of contaminated blood products. The decision established that the state’s responsibility could be engaged even in the absence of fault, on the basis of the principle of equality before public burdens (égalité devant les charges publiques). Where a public service — the blood transfusion service was a service public administratif — caused exceptional harm to a particular class of citizens, the state was required to compensate them even if no fault could be proved.
The decision was significant in two respects. First, it confirmed that victims of public health disasters could recover compensation from the state without having to prove negligence or fault on the part of individual officials. Second, it recognized that the principle of equality before public burdens applied to public health services, extending the scope of strict liability beyond the traditional categories of risque administratif and travaux publics.
The Fonds d’Indemnisation and Legislative Reforms
Parliament responded to the scandal by establishing the Fonds d’Indemnisation des Transfusés et Hémophiles (FITH) in 1991, a compensation fund designed to provide swift and comprehensive compensation to victims without requiring them to navigate complex litigation. The FITH was funded by the state and the pharmaceutical industry and was empowered to make offers of compensation that victims could accept or reject in favor of litigation. A 2000 law extended compensation to all victims of HIV infection through blood transfusions, regardless of when the infection occurred.
The scandal also produced major legislative reforms. The transfusion safety regime was completely restructured: the CNTS was dissolved, and a new agency — the Agence Française du Sang — was created to oversee blood transfusion safety. The 1993 law on blood safety and the 1998 law on the safety of health products established a rigorous regulatory framework for blood products, including mandatory virus inactivation, traceability requirements, and post-market surveillance. The scandal also contributed to the development of French bioethics law, culminating in the 1994 bioethics laws and the creation of the Agence de la Biomédecine.
Significance for French Law
The contaminated blood affair produced no single landmark case but rather a series of important legal developments across multiple domains of French law. In criminal law, the affair established that government officials could be held criminally responsible for failures to prevent public health disasters, though the threshold for establishing criminal fault in policy decisions remained high. In administrative law, the Consorts Nguyen decision expanded the scope of strict state liability for public health services, recognizing the principle of equality before public burdens as a basis for compensation. In constitutional law, the affair prompted the 1993 revision creating the Court of Justice of the Republic, institutionalizing a mechanism for ministerial criminal accountability.
The affair also had profound effects on the relationship between law, science, and public administration in France. It demonstrated that the administration of public health services was subject to legal accountability and that scientific uncertainty could not excuse inaction where the risk of catastrophic harm was known. It established the principle that victims of public health disasters are entitled to comprehensive compensation, regardless of fault. And it created a model for responding to public health emergencies that combines criminal accountability for egregious failures, administrative liability for systemic harm, and legislative compensation funds for victims. The contaminated blood affair remains the paradigmatic example of a public health disaster in French law and a cautionary tale about the consequences of prioritizing cost over safety in the administration of health services.